SI1163264T1 - Novel lhrh antagonists with improved solubility characteristics - Google Patents

Novel lhrh antagonists with improved solubility characteristics

Info

Publication number
SI1163264T1
SI1163264T1 SI200030505T SI200030505T SI1163264T1 SI 1163264 T1 SI1163264 T1 SI 1163264T1 SI 200030505 T SI200030505 T SI 200030505T SI 200030505 T SI200030505 T SI 200030505T SI 1163264 T1 SI1163264 T1 SI 1163264T1
Authority
SI
Slovenia
Prior art keywords
improved solubility
solubility characteristics
lhrh antagonists
novel lhrh
novel
Prior art date
Application number
SI200030505T
Other languages
English (en)
Slovenian (sl)
Inventor
Michael Bernd
Bernhard Kutscher
Eckhard Gnther
Peter Romeis
Thomas Reissmann
Thomas Beckers
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of SI1163264T1 publication Critical patent/SI1163264T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200030505T 1999-03-17 2000-03-11 Novel lhrh antagonists with improved solubility characteristics SI1163264T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19911771A DE19911771B4 (de) 1999-03-17 1999-03-17 LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung
PCT/EP2000/002165 WO2000055190A1 (fr) 1999-03-17 2000-03-11 Nouveaux antagonistes de l'hormone de declenchement de l'hormone luteinotrophe a proprietes de dissolution ameliorees
EP00910816A EP1163264B1 (fr) 1999-03-17 2000-03-11 Nouveaux antagonistes de l'hormone de declenchement de l'hormone luteinotrophe a proprietes de dissolution ameliorees

Publications (1)

Publication Number Publication Date
SI1163264T1 true SI1163264T1 (en) 2004-12-31

Family

ID=7901213

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200030505T SI1163264T1 (en) 1999-03-17 2000-03-11 Novel lhrh antagonists with improved solubility characteristics
SI200130882T SI1268522T1 (sl) 1999-03-17 2001-03-12 Novi antagonisti lhrh, njihova priprava in uporaba kot zdravila

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200130882T SI1268522T1 (sl) 1999-03-17 2001-03-12 Novi antagonisti lhrh, njihova priprava in uporaba kot zdravila

Country Status (33)

Country Link
US (3) US6627609B1 (fr)
EP (1) EP1163264B1 (fr)
JP (1) JP3801867B2 (fr)
KR (1) KR100569623B1 (fr)
CN (1) CN1185251C (fr)
AR (1) AR022970A1 (fr)
AT (1) ATE277077T1 (fr)
AU (1) AU759442B2 (fr)
BG (1) BG65283B1 (fr)
BR (1) BR0009472A (fr)
CA (1) CA2381461C (fr)
CO (1) CO5150192A1 (fr)
CZ (1) CZ301696B6 (fr)
DE (2) DE19911771B4 (fr)
DK (1) DK1163264T3 (fr)
ES (1) ES2225103T3 (fr)
HK (1) HK1045531B (fr)
HU (1) HU229672B1 (fr)
IL (3) IL145484A0 (fr)
MX (1) MXPA01010052A (fr)
NO (1) NO327753B1 (fr)
NZ (1) NZ514830A (fr)
PL (1) PL200647B1 (fr)
PT (1) PT1163264E (fr)
RU (1) RU2227145C2 (fr)
SI (2) SI1163264T1 (fr)
SK (1) SK287880B6 (fr)
TR (1) TR200103339T2 (fr)
TW (1) TWI243179B (fr)
UA (1) UA70997C2 (fr)
WO (1) WO2000055190A1 (fr)
YU (1) YU68702A (fr)
ZA (1) ZA200107753B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US5677184A (en) * 1994-04-19 1997-10-14 Takeda Chemical Industries, Ltd. CHO cells that express human LH-RH receptor
DE19911771B4 (de) 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung
US7005418B1 (en) 1999-09-23 2006-02-28 Zentaris Gmbh Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
NZ534836A (en) * 1999-09-23 2007-07-27 Zentaris Gmbh Method for the therapeutic management of extrauterine proliferatoin of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
NZ521273A (en) 2000-03-14 2005-01-28 Zentaris Gmbh Novel LHRH-antagonists, production and use thereof as medicament for hormone-dependant tumors, endometriosis, beign prostate hyperplasia and fertility disorders
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
PT1392348E (pt) * 2001-04-30 2008-09-09 Aeterna Zentaris Gmbh Tratamento de demência e doenças neurodegenerativas com doses intermédias de antagonistas de lhrh
SE0104462D0 (sv) * 2001-12-29 2001-12-29 Carlbiotech Ltd As Peptide purifcation (Peptidrening)
CN100509053C (zh) 2002-09-27 2009-07-08 赞塔里斯有限公司 持续释放的药物活性肽施用形式及其制备方法
CN100340572C (zh) * 2004-12-01 2007-10-03 中国人民解放军军事医学科学院毒物药物研究所 新的lhrh拮抗剂
CN101037472B (zh) * 2006-03-14 2013-03-27 中国人民解放军军事医学科学院毒物药物研究所 具有低组胺释放作用的促黄体生成素释放激素拮抗剂
EP1891964A1 (fr) * 2006-08-08 2008-02-27 AEterna Zentaris GmbH Utilisation de doses initiales d'analogues de LHRH et doses de maintenance d'antagonistes de LHRH pour le traitement de cancers dépendant des hormones
CN101597321B (zh) * 2008-06-03 2013-04-24 中国人民解放军军事医学科学院毒物药物研究所 长效低组胺释放副作用的lhrh拮抗剂
WO2012050892A2 (fr) * 2010-09-29 2012-04-19 Esperance Pharmaceuticals, Inc. Procédés pour stimuler, augmenter, ou améliorer l'anéantissement d'une cellule exprimant les récepteurs de l'hormone de libération de l'hormone lutéinisante (lhrh)
CN102584945A (zh) * 2012-02-09 2012-07-18 深圳翰宇药业股份有限公司 一种醋酸加尼瑞克的制备方法
CN103524599B (zh) * 2012-07-05 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 环肽lhrh拮抗剂衍生物及其药物用途
CN104231055A (zh) * 2013-06-18 2014-12-24 深圳翰宇药业股份有限公司 加尼瑞克前体以及由其制备醋酸加尼瑞克的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581169A (en) 1982-12-21 1986-04-08 Syntex (U.S.A.) Inc. Nona-peptide and deca-peptide analogs of LHRH, useful as LHRH antagonists
DE3467173D1 (en) 1983-08-16 1987-12-10 Akzo Nv Lh- rh antagonists
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
US5140009A (en) 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists
US5300492A (en) * 1988-02-10 1994-04-05 Tap Pharmaceuticals LHRH analogs
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
EP0328090A3 (fr) * 1988-02-10 1990-08-16 Abbott Laboratories Analogues du LHRH
DE4117507A1 (de) 1991-05-24 1992-11-26 Schering Ag Verfahren zur herstellung von n(pfeil hoch)6(pfeil hoch)-substituierten lysin-derivaten
DE19544212A1 (de) * 1995-11-28 1997-06-05 Asta Medica Ag Neue LH-RH-Antagonisten mit verbesserter Wirkung
US5942493A (en) * 1995-11-28 1999-08-24 Asta Medica Aktiengesellschaft LH-RH antagonists having improved action
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer
US5968895A (en) 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung
US6586403B1 (en) * 2000-07-20 2003-07-01 Salpep Biotechnology, Inc. Treating allergic reactions and inflammatory responses with tri-and dipeptides
KR100876538B1 (ko) * 2000-08-17 2008-12-31 아에테르나 젠타리스 게엠베하 Ｌｈｒｈ 길항제의 염의 제조방법

Also Published As

Publication number Publication date
WO2000055190A1 (fr) 2000-09-21
KR20020002482A (ko) 2002-01-09
HK1045531A1 (en) 2002-11-29
SI1268522T1 (sl) 2009-02-28
NO20014486L (no) 2001-11-02
AU3288700A (en) 2000-10-04
US6627609B1 (en) 2003-09-30
HUP0200363A2 (en) 2002-06-28
CA2381461A1 (fr) 2000-09-21
UA70997C2 (uk) 2004-11-15
US20060281685A1 (en) 2006-12-14
ATE277077T1 (de) 2004-10-15
HU229672B1 (en) 2014-04-28
CA2381461C (fr) 2011-01-04
PL351792A1 (en) 2003-06-16
HUP0200363A3 (en) 2002-09-30
SK287880B6 (sk) 2012-02-03
CN1348462A (zh) 2002-05-08
NO20014486D0 (no) 2001-09-14
IL145484A (en) 2006-12-31
US20040266695A1 (en) 2004-12-30
ZA200107753B (en) 2002-05-13
BG106008A (en) 2002-06-28
TR200103339T2 (tr) 2002-04-22
YU68702A (sh) 2006-01-16
DK1163264T3 (da) 2004-12-06
CN1185251C (zh) 2005-01-19
AU759442B2 (en) 2003-04-17
DE19911771B4 (de) 2006-03-30
EP1163264B1 (fr) 2004-09-22
NZ514830A (en) 2003-05-30
PT1163264E (pt) 2004-12-31
IL151647A (en) 2009-08-03
AR022970A1 (es) 2002-09-04
CZ301696B6 (cs) 2010-05-26
US7732412B2 (en) 2010-06-08
IL145484A0 (en) 2002-06-30
HK1045531B (zh) 2005-05-20
CZ20013318A3 (cs) 2002-05-15
BG65283B1 (bg) 2007-11-30
JP3801867B2 (ja) 2006-07-26
JP2002543045A (ja) 2002-12-17
NO327753B1 (no) 2009-09-14
PL200647B1 (pl) 2009-01-30
EP1163264A1 (fr) 2001-12-19
CO5150192A1 (es) 2002-04-29
SK13232001A3 (sk) 2002-05-09
RU2227145C2 (ru) 2004-04-20
DE19911771A1 (de) 2000-09-28
MXPA01010052A (es) 2003-07-14
BR0009472A (pt) 2001-11-27
DE50007905D1 (de) 2004-10-28
TWI243179B (en) 2005-11-11
US7148195B2 (en) 2006-12-12
KR100569623B1 (ko) 2006-04-11
ES2225103T3 (es) 2005-03-16

Similar Documents

Publication Publication Date Title
EP1206262A4 (fr) Antagonistes des neuropeptides y: derives de spiroisoquinolinone
IL145484A0 (en) Novel lhrh antagonists with improved solubility characteristics
GB2352880B (en) Alternator
HK1043590A1 (zh) 毒蕈碱性拮抗物
HK1048307A1 (zh) 取代的雜環基-2h-苯並吡喃類化合物
GB9922942D0 (en) Catch
HUP0201201A3 (en) Endoparasiticidal agents
TW392548U (en) Improved socket structure
GB9911456D0 (en) Oligohydroxyl substituted 3-urea-benzofurane-and-pyridofurane-derivatives
TW403007U (en) Improved socket structure
PL352101A1 (en) Substituted phenylcyclohexanocarboxyamides
TW435204U (en) Marking-type injector
TW433433U (en) Improved lampstand
TW410560U (en) Improved pin structure
CA85738S (en) Cup
TW401794U (en) Improved cup
TW417922U (en) Catch structure
GB9923645D0 (en) Improved bollard
TW401901U (en) Improved socket structure
TW385836U (en) Pin structure
GB9905027D0 (en) Waterer
HU9900182V0 (en) Parloor game
GB9923136D0 (en) Game
GB9904243D0 (en) Game
GB9907024D0 (en) Game